ECCO consensus: evidence-based use of 6-thioguanine therapy in Crohn's disease?
Nanne K H
NK
de Boer
Dirk P
DP
van Asseldonk
Adriaan
A
van Bodegraven
D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D006975:Hypertension, Portal / Q000139:chemically induced; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013866:Thioguanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D007155:Immunologic Factors; D013866:Thioguanine